Clinical Trial Update: Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial examining mechanisms underlying energetic impairment in cardiac and skeletal muscle in diabetes, focusing on diabetic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Cardiomyopathy

Snippet

Sponsor: University Hospital Birmingham | Conditions: Diabetic Cardiomyopathy | Phase 1, Phase 2 | Status: UNKNOWN